No takes yet. Share an insight, caveat, or question.
Preclinical study reveals that nucleophosmin promotes WNT-driven tumorigenesis by preventing ribosomal stress and p53 activation, highlighting a therapeutic target in colorectal cancer.
Kanellos et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: